Search results

Defence Materials Technology Centre honours achievements of two ANSTO collaborators.

A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.

Research undertaken to understand ancient record of algal blooms

Congress marks watershed moment for nuclear medicine and ANSTO

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Padstow North and Caringbah North selected as winners of ANSTO's Top Coder competition.

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.

Scientists from UNSW and ANSTO have characterised the structure of two-dimensional transition metal carbides, carbonites, and nitrides (MXenes) materials, that could be used as a lightweight fire-retardant filler and in energy storage devices.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Neutron scattering has contributed to a 'tour de force' of chemistry led by Monash University.

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.